Works matching IS 15588211 AND DT 2021 AND VI 16 AND IP 2

Results: 11

Antibody-Based Treatment Approaches in Multiple Myeloma.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 183, doi. 10.1007/s11899-021-00624-6

By:

Hosoya, Hitomi;
Sidana, Surbhi

Publication type:

Article

The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 132, doi. 10.1007/s11899-021-00620-w

By:

Banerjee, Rahul;
Kelkar, Amar H.;
Logan, Aaron C.;
Majhail, Navneet S.;
Pemmaraju, Naveen

Publication type:

Article

Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 126, doi. 10.1007/s11899-021-00627-3

By:

Miller, Tamara P.;
Aplenc, Richard

Publication type:

Article

Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 148, doi. 10.1007/s11899-021-00631-7

By:

Marneni, Naimisha;
Chakraborty, Rajshekhar

Publication type:

Article

Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies—Are We Close?

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 117, doi. 10.1007/s11899-021-00629-1

By:

Kuczmarski, Thomas M.;
Odejide, Oreofe O.

Publication type:

Article

Enteropathy-Associated T cell Lymphoma.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 140, doi. 10.1007/s11899-021-00634-4

By:

Al Somali, Zakiah;
Hamadani, Mehdi;
Kharfan-Dabaja, Mohamed;
Sureda, Ana;
El Fakih, Riad;
Aljurf, Mahmoud

Publication type:

Article

MRD Assessment in Multiple Myeloma: Progress and Challenges.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 162, doi. 10.1007/s11899-021-00633-5

By:

Bertamini, Luca;
D'Agostino, Mattia;
Gay, Francesca

Publication type:

Article

Progress in the Management of Smoldering Multiple Myeloma.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 172, doi. 10.1007/s11899-021-00623-7

By:

Schmidt, Timothy M.;
Callander, Natalie S.

Publication type:

Article

Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 192, doi. 10.1007/s11899-021-00621-9

By:

Grieselhuber, Nicole R.;
Mims, Alice S.

Publication type:

Article

Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 218, doi. 10.1007/s11899-021-00628-2

By:

Schwerdtfeger, Melanie;
Benmebarek, Mohamed-Reda;
Endres, Stefan;
Subklewe, Marion;
Desiderio, Vincenzo;
Kobold, Sebastian

Publication type:

Article

IDH Inhibitors in AML—Promise and Pitfalls.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 2, p. 207, doi. 10.1007/s11899-021-00619-3

By:

McMurry, Hannah;
Fletcher, Luke;
Traer, Elie

Publication type:

Article